Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives Average Rating of “Buy” from Brokerages

Share on StockTwits

Intuitive Surgical, Inc. (NASDAQ:ISRG) has been assigned a consensus recommendation of “Buy” from the eighteen research firms that are covering the company, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and twelve have given a buy rating to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $578.93.

ISRG has been the subject of several recent analyst reports. BTIG Research reiterated a “hold” rating on shares of Intuitive Surgical in a report on Sunday, April 21st. Citigroup upgraded shares of China Petroleum & Chemical from a “neutral” rating to a “buy” rating in a report on Tuesday, May 14th. Deutsche Bank initiated coverage on shares of Intuitive Surgical in a report on Monday, April 1st. They set a “buy” rating and a $630.00 target price for the company. Canaccord Genuity initiated coverage on shares of Zynerba Pharmaceuticals in a report on Monday, April 22nd. They set a “buy” rating and a $8.09 target price for the company. Finally, Raymond James restated a “buy” rating on shares of West Fraser Timber in a report on Monday, April 22nd.

In related news, VP Jamie Samath sold 260 shares of the company’s stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $500.00, for a total value of $130,000.00. Following the completion of the sale, the vice president now owns 278 shares in the company, valued at approximately $139,000. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Curet Myriam sold 2,200 shares of the company’s stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $493.26, for a total transaction of $1,085,172.00. Following the completion of the sale, the executive vice president now owns 3,101 shares of the company’s stock, valued at approximately $1,529,599.26. The disclosure for this sale can be found here. Insiders have sold 27,621 shares of company stock valued at $13,828,454 over the last 90 days. 1.70% of the stock is currently owned by insiders.

Large investors have recently modified their holdings of the stock. Icon Wealth Partners LLC purchased a new stake in Intuitive Surgical in the 1st quarter worth approximately $26,000. Stone House Investment Management LLC acquired a new position in shares of Intuitive Surgical during the 1st quarter worth $31,000. Advisory Alpha LLC acquired a new position in shares of Intuitive Surgical during the 1st quarter worth $32,000. Ellis Investment Partners LLC acquired a new position in shares of Intuitive Surgical during the 1st quarter worth $34,000. Finally, Liberty Wealth Management LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter worth $37,000. Institutional investors and hedge funds own 85.56% of the company’s stock.

Shares of Intuitive Surgical stock traded up $6.67 on Friday, hitting $530.17. The company had a trading volume of 285,766 shares, compared to its average volume of 583,721. The business has a 50-day simple moving average of $511.58. The stock has a market cap of $60.47 billion, a P/E ratio of 55.87, a PEG ratio of 4.50 and a beta of 1.08. Intuitive Surgical has a 52 week low of $430.24 and a 52 week high of $589.32.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $2.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.70 by ($0.09). The company had revenue of $974.00 million during the quarter, compared to the consensus estimate of $975.27 million. Intuitive Surgical had a net margin of 29.78% and a return on equity of 17.33%. The company’s revenue was up 14.9% on a year-over-year basis. During the same quarter last year, the business earned $2.44 earnings per share. On average, research analysts anticipate that Intuitive Surgical will post 9.4 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

Featured Article: What Are Cryptocurrencies?

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.